Difference between revisions of "Low-grade papillary urothelial carcinoma"
Jump to navigation
Jump to search
(→Image) |
|||
| (3 intermediate revisions by the same user not shown) | |||
| Line 13: | Line 13: | ||
| IF = | | IF = | ||
| Gross = exophytic lesion, frond-like appearance, friable | | Gross = exophytic lesion, frond-like appearance, friable | ||
| Grossing = | | Grossing = [[radical cystectomy grossing]], [[cystoprostatectomy grossing]], [[nephroureterectomy grossing]] | ||
| Staging = [[bladder cancer staging]] | |||
| Site = [[urothelium]] | | Site = [[urothelium]] | ||
| Assdx = | | Assdx = | ||
| Line 74: | Line 75: | ||
**The three most predictive features of high-grade are ''architectural complexity'', ''nuclear size variation'', and ''absence of umbrella cells''.<ref name=pmid21980608>{{Cite journal | last1 = Isfoss | first1 = BL. | last2 = Majak | first2 = B. | last3 = Busch | first3 = C. | last4 = Braathen | first4 = GJ. | title = Simplification of grading papillary urothelial neoplasia using a reduced set of diagnostic features. | journal = Anal Quant Cytol Histol | volume = 33 | issue = 2 | pages = 68-74 | month = Apr | year = 2011 | doi = | PMID = 21980608 }}</ref> | **The three most predictive features of high-grade are ''architectural complexity'', ''nuclear size variation'', and ''absence of umbrella cells''.<ref name=pmid21980608>{{Cite journal | last1 = Isfoss | first1 = BL. | last2 = Majak | first2 = B. | last3 = Busch | first3 = C. | last4 = Braathen | first4 = GJ. | title = Simplification of grading papillary urothelial neoplasia using a reduced set of diagnostic features. | journal = Anal Quant Cytol Histol | volume = 33 | issue = 2 | pages = 68-74 | month = Apr | year = 2011 | doi = | PMID = 21980608 }}</ref> | ||
**Stanford criteria has a 5% rule -- if the high-grade component is <5% it is low-grade.<ref>URL: [http://surgpathcriteria.stanford.edu/bladder/tcc-papillary-transitional-urothelial-carcinoma/ http://surgpathcriteria.stanford.edu/bladder/tcc-papillary-transitional-urothelial-carcinoma/]. Accessed on: 27 January 2014.</ref> | **Stanford criteria has a 5% rule -- if the high-grade component is <5% it is low-grade.<ref>URL: [http://surgpathcriteria.stanford.edu/bladder/tcc-papillary-transitional-urothelial-carcinoma/ http://surgpathcriteria.stanford.edu/bladder/tcc-papillary-transitional-urothelial-carcinoma/]. Accessed on: 27 January 2014.</ref> | ||
***There is some evidence to suggest low-grade with <5% high-grade behaves similar to low-grade.<ref name=pmid26520419>{{Cite journal | last1 = Reis | first1 = LO. | last2 = Taheri | first2 = D. | last3 = Chaux | first3 = A. | last4 = Guner | first4 = G. | last5 = Mendoza Rodriguez | first5 = MA. | last6 = Bivalacqua | first6 = TJ. | last7 = Schoenberg | first7 = MP. | last8 = Epstein | first8 = JI. | last9 = Netto | first9 = GJ. | title = Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladder. | journal = Hum Pathol | volume = 47 | issue = 1 | pages = 20-5 | month = Jan | year = 2016 | doi = 10.1016/j.humpath.2015.09.007 | PMID = 26520419 }}></ref> | |||
*[[Inverted urothelial papilloma]] - often have peripheral palisading. | *[[Inverted urothelial papilloma]] - often have peripheral palisading. | ||
*[[Urothelial papilloma]]. | *[[Urothelial papilloma]]. | ||
| Line 100: | Line 102: | ||
==Sign out== | ==Sign out== | ||
<pre> | |||
Urinary Bladder Tumour, Transurethral Resection: | |||
- LOW GRADE PAPILLARY UROTHELIAL CARCINOMA. | |||
-- NEGATIVE for lamina propria invasion. | |||
- NEGATIVE for carcinoma in situ. | |||
- Benign muscularis propria present. | |||
</pre> | |||
<pre> | |||
Urinary Bladder Tumour, Transurethral Resection: | |||
- LOW-GRADE PAPILLARY UROTHELIAL CARCINOMA. | |||
-- NEGATIVE for lamina propria invasion. | |||
- NEGATIVE for carcinoma in situ. | |||
- Definite muscularis propria ABSENT. | |||
</pre> | |||
====Block letters==== | |||
<pre> | <pre> | ||
URINARY BLADDER LESION ("TUMOUR"), TRANSURETHRAL RESECTION: | URINARY BLADDER LESION ("TUMOUR"), TRANSURETHRAL RESECTION: | ||
Latest revision as of 13:31, 27 April 2016
| Low-grade papillary urothelial carcinoma | |
|---|---|
| Diagnosis in short | |
 Low-grade papillary urothelial carcinoma. H&E stain. | |
|
| |
| LM | papillae (fibrovascular cores covered by urothelium) -- usually with fusion and branching, small nuclei (~3x a resting lymphocyte), +/-invasion into the lamina propria (rare), +/-mitoses (uncommon) |
| LM DDx | PUNLMP, urothelial papilloma, inverted papilloma, high-grade papillary urothelial carcinoma |
| IHC | Ki-67 low (<25% of cells) |
| Gross | exophytic lesion, frond-like appearance, friable |
| Grossing notes | radical cystectomy grossing, cystoprostatectomy grossing, nephroureterectomy grossing |
| Staging | bladder cancer staging |
| Site | urothelium |
|
| |
| Syndromes | Lynch syndrome |
|
| |
| Signs | hematuria |
| Prevalence | very common |
| Prognosis | very good |
| Clin. DDx | high-grade papillary urothelial carcinoma, urothelial papilloma |
Low-grade papillary urothelial carcinoma, abbreviated LGPUC,[1] is a very common indolent form of cancer that arises from the urothelium.
It is also known as low-grade papillary urothelial cell carcinoma, abbreviated LGPUCC.
General
- Very common.
- Very good prognosis - if it is non-invasive.
- Usually non-invasive.[2]
Note:
- Invasive low-grade UCC is:[2]
- ~75% nested variant of urothelial carcinoma.
- ~25: low-grade papillary urothelial carcinoma.
Gross
- Exophytic lesion.
- Frond-like appearance.
Microscopic
Features:[3]
- Papillae = fibrovascular cores covered by urothelium.
- Usually with fusion of papillae and branching of papillae.
- Small nuclei (~3x a resting lymphocyte).
- +/-Invasion into the lamina propria (rare).
- Rare mitoses.
- Usually difficult to find.
- Basal location.
Criteria for invasion (mnemonic PISS-R):[2]
- Stromal reaction.
- Infiltrating single cells.
- Small nests.
- Retraction artifact.
- Paradoxical differentiation.
Note:
- Nuclei slightly larger than in PUNLMPs.
- The presence/absence of muscle should be commented on in biopsy specimens.
- Adipose tissue may be seen in the lamina propria; tumour adjacent to adipose tissue on a biopsy does not imply invasion deep to the muscularis propria.[4]
DDx:
- PUNLMP.
- High grade papillary urothelial carcinoma.
- Often under-diagnosed (~15% in one series) when reassessed by experts.[5]
- The three most predictive features of high-grade are architectural complexity, nuclear size variation, and absence of umbrella cells.[6]
- Stanford criteria has a 5% rule -- if the high-grade component is <5% it is low-grade.[7]
- There is some evidence to suggest low-grade with <5% high-grade behaves similar to low-grade.[8]
- Inverted urothelial papilloma - often have peripheral palisading.
- Urothelial papilloma.
Image
LGPUC - intermed. mag.
LGPUC - high mag.
LGPUC - high mag.
IHC
- Ki-67:
Molecular
Molecular changes:[12]
- FGFR3
- HRAS
- Loss of heterozygosity - chromosome 9.
Note:
- Not currently used diagnostically.
Sign out
Urinary Bladder Tumour, Transurethral Resection: - LOW GRADE PAPILLARY UROTHELIAL CARCINOMA. -- NEGATIVE for lamina propria invasion. - NEGATIVE for carcinoma in situ. - Benign muscularis propria present.
Urinary Bladder Tumour, Transurethral Resection: - LOW-GRADE PAPILLARY UROTHELIAL CARCINOMA. -- NEGATIVE for lamina propria invasion. - NEGATIVE for carcinoma in situ. - Definite muscularis propria ABSENT.
Block letters
URINARY BLADDER LESION ("TUMOUR"), TRANSURETHRAL RESECTION:
- LOW-GRADE PAPILLARY UROTHELIAL CARCINOMA.
-- NEGATIVE FOR LAMINA PROPRIA INVASION.
- NO MUSCULARIS PROPRIA IDENTIFIED.
Muscularis propria present
URINARY BLADDER LESION ("TUMOUR"), TRANSURETHRAL RESECTION:
- LOW-GRADE PAPILLARY UROTHELIAL CARCINOMA.
-- NEGATIVE FOR LAMINA PROPRIA INVASION.
- BENIGN MUSCULARIS PROPRIA PRESENT.
Micro
The sections show urothelial mucosa with a tumour with fibrovascular cores. The nuclei are of uniform size (2-3 times a resting lymphocytes). Rare foci of degenerative cells are seen. The papillary structures are thick and appear to compress the lamina propria. Rare mitotic figures are identified. No atypical mitoses are apparent. No lamina propria invasion is identified. No muscularis propria is identified.
See also
References
- ↑ Watts, KE.; Montironi, R.; Mazzucchelli, R.; van der Kwast, T.; Osunkoya, AO.; Stephenson, AJ.; Hansel, DE. (Aug 2012). "Clinicopathologic characteristics of 23 cases of invasive low-grade papillary urothelial carcinoma.". Urology 80 (2): 361-6. doi:10.1016/j.urology.2012.04.010. PMID 22857755.
- ↑ 2.0 2.1 2.2 Toll, AD.; Epstein, JI. (Jul 2012). "Invasive low-grade papillary urothelial carcinoma: a clinicopathologic analysis of 41 cases.". Am J Surg Pathol 36 (7): 1081-6. doi:10.1097/PAS.0b013e318253d6e0. PMID 22510761.
- ↑ Humphrey, Peter A; Dehner, Louis P; Pfeifer, John D (2008). The Washington Manual of Surgical Pathology (1st ed.). Lippincott Williams & Wilkins. pp. 310. ISBN 978-0781765275.
- ↑ Bochner, BH.; Nichols, PW.; Skinner, DG. (Mar 1995). "Overstaging of transitional cell carcinoma: clinical significance of lamina propria fat within the urinary bladder.". Urology 45 (3): 528-31. doi:10.1016/S0090-4295(99)80030-2. PMID 7879346.
- ↑ Miyamoto, H.; Brimo, F.; Schultz, L.; Ye, H.; Miller, JS.; Fajardo, DA.; Lee, TK.; Epstein, JI. et al. (Aug 2010). "Low-grade papillary urothelial carcinoma of the urinary bladder: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center.". Arch Pathol Lab Med 134 (8): 1160-3. doi:10.1043/2009-0403-OA.1. PMID 20670136.
- ↑ Isfoss, BL.; Majak, B.; Busch, C.; Braathen, GJ. (Apr 2011). "Simplification of grading papillary urothelial neoplasia using a reduced set of diagnostic features.". Anal Quant Cytol Histol 33 (2): 68-74. PMID 21980608.
- ↑ URL: http://surgpathcriteria.stanford.edu/bladder/tcc-papillary-transitional-urothelial-carcinoma/. Accessed on: 27 January 2014.
- ↑ Reis, LO.; Taheri, D.; Chaux, A.; Guner, G.; Mendoza Rodriguez, MA.; Bivalacqua, TJ.; Schoenberg, MP.; Epstein, JI. et al. (Jan 2016). "Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladder.". Hum Pathol 47 (1): 20-5. doi:10.1016/j.humpath.2015.09.007. PMID 26520419.>
- ↑ Rajcani, J.; Kajo, K.; Adamkov, M.; Moravekova, E.; Lauko, L.; Felcanova, D.; Bencat, M. (2013). "Immunohistochemical characterization of urothelial carcinoma.". Bratisl Lek Listy 114 (8): 431-8. PMID 23944616.
- ↑ Pich, A.; Chiusa, L.; Comino, A.; Navone, R. (1994). "Cell proliferation indices, morphometry and DNA flow cytometry provide objective criteria for distinguishing low and high grade bladder carcinomas.". Virchows Arch 424 (2): 143-8. PMID 7910097.
- ↑ Mai, KT.; Flood, TA.; Williams, P.; Kos, Z.; Belanger, EC. (Oct 2013). "Mixed low- and high-grade papillary urothelial carcinoma: histopathogenetic and clinical significance.". Virchows Arch 463 (4): 575-81. doi:10.1007/s00428-013-1456-7. PMID 23913166.
- ↑ Ehdaie, B.; Theodorescu, D. (Jan 2008). "Molecular markers in transitional cell carcinoma of the bladder: New insights into mechanisms and prognosis.". Indian J Urol 24 (1): 61-7. doi:10.4103/0970-1591.38606. PMC 2684226. PMID 19468362. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2684226/.